Dr. Jason Crowell talks with Dr. Christopher Gibbons about the need for accurate diagnostic and prognostic biomarkers for MSA and its differentiation from other synucleinopathies.
Read the related article in Neurology.
Disclosures can be found at Neurology.org.
Activity